- Display 15 Products per page
The Global Market for Medical Devices, 10th Edition (45 Specific Device Markets and 50 Country Markets Forecasted to 2024)
Published: October 28, 2019 | Price: $4,000.00 – $8,000.00
The Global Market for Medical Devices, 10th edition, provides a comprehensive view of the medical device market and opportunity for medical device manufacturers, competitors, and investors. The report examines the companies in the market, the types of devices sold across the global market, and the country markets they are sold in. As part of its coverage, this report contains market sizing and forecasts for the world medical device market and the medical device markets of 50 countries, providing the following...
Exome Sequencing Market
Published: November 25, 2019 | Price: $4,000.00 – $8,000.00
The increasing popularity of next-generation systems has fueled systems and sequencers, but the cost of sequencing – despite price declines – has led to demands for more efficient methods. Exome Sequencing is a widely used NGS technique that sequences all the exons in a genome. Rather than sequencing the entire human genome, only pieces of an individual's DNA that provide instructions for making proteins are sequenced. These pieces, called exons, are thought to make up roughly 2 percent of a...
CAR-T Cell Therapy Market Review
Published: December 19, 2019 | Price: $4,000.00 – $8,000.00
CAR-T cell therapy is a form of immunotherapy that utilizes the body’s own T cells to target and destroy cancer cells. This therapy is a personalized form of treatment, meaning that each patient receives T cells that are geared specifically toward his or her cancer diagnosis. T-cell therapy works by removing existing T cells from a patient and having them grown and modified in a lab. These new T cells are given a gene for a specialized receptor, known as...
The Market and Future Potential for Molecular Point of Care
Published: March 11, 2020 | Price: $4,000.00 – $8,000.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche compete in this segment, influenza competitors Sekisui and Quidel also operate, as do specialty concerns such as Curetis, Biocartis, and a host of small but innovative players. Molecular point of care or...
Artificial Intelligence Markets in IVD
Published: April 7, 2020 | Price: $4,000.00 – $8,000.00
The past few years has seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market and many more are in development. In recent years, diagnostics companies – in collaboration with AI companies – have begun implementing increasingly sophisticated machine learning techniques to improve the power of data analysis for patient care. The goal is to use developed algorithms to standardize and aid interpretation of...
COVID-19 Clinical Lab Tracker
Published: July 21, 2020 | Price: $7,500.00 Original price was: $7,500.00.$4,000.00Current price is: $4,000.00.
Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline
Published: April 21, 2020 | Price: $4,000.00 – $8,000.00
The vaccine market is poised for a rather substantial increase in the next five years due to the number of vaccines in development and the push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, companies stepped up to the challenge, scrambling to provide a potential vaccine. In addition to discussion of COVID-19 vaccine development as it stands currently, this report examines the market for human vaccines used to prevent various types of disease, focusing on commercialized vaccines and...
Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets
Published: May 14, 2020 | Price: $4,000.00 – $8,000.00
CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the fields of molecular diagnostics, vaccines and telehealth for decades. These important industries, already growing in revenues and number of competitors, now find themselves part of...
COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets
Published: November 2, 2020 | Price: $4,000.00 – $8,000.00
COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: COVID-19 has seen the molecular in...
Vaccines 2020: World Market Analysis, Players, Trends
Published: November 4, 2020 | Price: $4,000.00 – $8,000.00
Vaccine Market Tops 37 Billion, Says Kalorama Information Report In 2020, the global market for preventive vaccines is valued at $37.4 billion, up overall from $30.7 billion in 2015. The finding was made in Kalorama Information's report, Vaccines 2020. Strong continued growth in the global vaccines market is expected through 2025. THE MOST CURRENT VACCINE MARKET INFORMATION The vaccine market is a growth market for the experienced competitors participating in it.Seven billion dollars in new sales have occurred in the past...
Genetic Testing Markets for Epilepsy, Autism, Alzheimer’s and Other Neurologic Conditions
Published: January 4, 2021 | Price: $4,000.00 – $8,000.00
Genetic involvement in the pathogenesis of neurological disease is significant. Central nervous system disorders account for approximately 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases. Neurological diseases, especially brain diseases, are the last frontier in medical discovery. Advances in testing such as next-generation sequencing have been instrumental in identifying genetic causes for neurological conditions. The area of inherited condition testing for neurological conditions has become a major area of activity in the last decade or so,...
IVD Procedure Volumes 2020-2025: Immunoassays, POC, Chemistry, Molecular, Microbiology and Other Tests
Published: February 23, 2021 | Price: $4,000.00 – $8,000.00
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2020-2025 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business...
The Market and Potential for Molecular Point of Care 2021
Published: January 22, 2021 | Price: $4,000.00 – $8,000.00
This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular point of care or mPOC systems are designed to be faster than lab-based tests while more accurate than existing point of care systems. Development of...
Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs)
Published: April 12, 2021 | Price: $4,000.00 – $8,000.00
Contract manufacturing is an increasing part of the pharmaceutical business. In cell therapy this need is magnified because of the demand for cell and gene therapy products. Kalorama Information's report the Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs) details the following: Biopharmaceutical Contract Manufacturing Market Role Services Offered Usage Drivers Profiles of Companies, Key Players, and Competitors in the Market COVID-19’s Challenges and Opportunities for CMOs Global and Regional Market Overviews—U.S., Europe, and Other Nations New Developments and...
The Global Market for Medical Devices, 11th Edition
Published: April 21, 2021 | Price: $4,000.00 – $8,000.00
The medical device industry has unique challenges and opportunities. During 2020, many of these challenges, and opportunities, were highlighted even more so. It is a heavily regulated industry in most nations of the world. Devices need to be approved for reimbursement and prices are negotiated in many cases by group purchasing organizations and governments. Companies in the field must make constant research and development investments to produce the innovations that drive market success. Yet, despite these challenges, devices also benefit...